1-3 of 3
Erica Rappold
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Parsaclisib in Combination with Rituximab, Bendamustine + Rituximab, or Ibrutinib in Patients with Previously Treated B-Cell Lymphoma: Analysis of a Phase 1 Dose-Finding Study (CITADEL-112)

Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Teng Liu, Erica Rappold, Peter Langmuir, Armando Lopez-Guillermo
Journal: Blood
Blood (2022) 140 (Supplement 1): 9328–9330.
https://doi.org/10.1182/blood-2022-159703
Published: 2022
Journal Articles

Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma: Primary Analysis from a Phase 2 Study (CITADEL-204)

Tycel Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S. Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Peter Johnson
Journal: Blood
Blood (2021) 138 (Supplement 1): 44.
https://doi.org/10.1182/blood-2021-147778
Published: 2021
Journal Articles

Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Tycel J. Phillips, MD, Paolo Corradini, Ronit Gurion, MD, Caterina Patti, MD, Monica Tani, MD, Abraham Avigdor, MD, Wojciech Jurczak, MD PhD, Amitkumar Mehta, MD, Pier Luigi Zinzani, MD, Izidore S. Lossos, MD, Catherine Thieblemont, MD PhD, Fred Zheng, MD, Erica Rappold, Wanying Zhao, Peter Johnson, MD FRCP
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-134451
Published: 2020